ATE396997T1 - Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel - Google Patents
Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittelInfo
- Publication number
- ATE396997T1 ATE396997T1 AT06723254T AT06723254T ATE396997T1 AT E396997 T1 ATE396997 T1 AT E396997T1 AT 06723254 T AT06723254 T AT 06723254T AT 06723254 T AT06723254 T AT 06723254T AT E396997 T1 ATE396997 T1 AT E396997T1
- Authority
- AT
- Austria
- Prior art keywords
- bizyclic
- benzimidazoles
- pyrrolidino
- substituted
- production
- Prior art date
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical class C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
- 208000020450 carbohydrate metabolism disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 208000017745 inborn carbohydrate metabolic disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005012872A DE102005012872A1 (de) | 2005-03-19 | 2005-03-19 | Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396997T1 true ATE396997T1 (de) | 2008-06-15 |
Family
ID=36579682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06723254T ATE396997T1 (de) | 2005-03-19 | 2006-03-07 | Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7569700B2 (enExample) |
| EP (1) | EP1863817B1 (enExample) |
| JP (1) | JP2008533064A (enExample) |
| AT (1) | ATE396997T1 (enExample) |
| AU (1) | AU2006226637A1 (enExample) |
| BR (1) | BRPI0608456A2 (enExample) |
| CA (1) | CA2602229A1 (enExample) |
| DE (2) | DE102005012872A1 (enExample) |
| IL (1) | IL185805A0 (enExample) |
| MX (1) | MX2007010841A (enExample) |
| WO (1) | WO2006099940A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102260265B (zh) * | 2010-05-24 | 2015-09-02 | 上海阳帆医药科技有限公司 | 六氢吡咯[3,4-b]吡咯衍生物、其制备方法及其用途 |
| TW202220968A (zh) * | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| HUE066335T2 (hu) | 2018-10-05 | 2024-07-28 | Annapurna Bio Inc | Vegyületek és készítmények APJ receptor aktivitáshoz kapcsolódó állapotok kezelésére |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2249237T3 (es) * | 2000-01-05 | 2006-04-01 | Pfizer Inc. | Compuestos de bencimidazol como antagonistas del receptor orl1. |
| DK1341774T3 (da) * | 2000-12-06 | 2006-06-12 | Hoffmann La Roche | Kondenserede heteroaromatiske glucokinase-aktivatorer |
| US6855708B2 (en) * | 2001-03-20 | 2005-02-15 | Merck & Co., Inc. | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| WO2004011440A1 (ja) * | 2002-07-30 | 2004-02-05 | Banyu Pharmaceutical Co., Ltd. | ベンズイミダゾール誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤 |
| JP4909068B2 (ja) * | 2003-02-14 | 2012-04-04 | グラクソ グループ リミテッド | カルボキサミド誘導体 |
| WO2005035526A1 (en) * | 2003-10-09 | 2005-04-21 | Argenta Discovery Ltd. | Bicyclic compounds and their therapeutic use |
-
2005
- 2005-03-19 DE DE102005012872A patent/DE102005012872A1/de not_active Withdrawn
-
2006
- 2006-03-07 AU AU2006226637A patent/AU2006226637A1/en not_active Abandoned
- 2006-03-07 AT AT06723254T patent/ATE396997T1/de not_active IP Right Cessation
- 2006-03-07 MX MX2007010841A patent/MX2007010841A/es not_active Application Discontinuation
- 2006-03-07 CA CA002602229A patent/CA2602229A1/en not_active Abandoned
- 2006-03-07 BR BRPI0608456-7A patent/BRPI0608456A2/pt not_active Application Discontinuation
- 2006-03-07 DE DE502006000850T patent/DE502006000850D1/de active Active
- 2006-03-07 EP EP06723254A patent/EP1863817B1/de not_active Not-in-force
- 2006-03-07 JP JP2008501194A patent/JP2008533064A/ja not_active Abandoned
- 2006-03-07 WO PCT/EP2006/002055 patent/WO2006099940A1/de not_active Ceased
-
2007
- 2007-09-06 IL IL185805A patent/IL185805A0/en unknown
- 2007-09-14 US US11/855,224 patent/US7569700B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008533064A (ja) | 2008-08-21 |
| WO2006099940A1 (de) | 2006-09-28 |
| DE502006000850D1 (de) | 2008-07-10 |
| BRPI0608456A2 (pt) | 2010-01-05 |
| US20080090890A1 (en) | 2008-04-17 |
| MX2007010841A (es) | 2007-11-09 |
| IL185805A0 (en) | 2008-01-06 |
| EP1863817B1 (de) | 2008-05-28 |
| DE102005012872A1 (de) | 2006-09-28 |
| WO2006099940A8 (de) | 2006-11-09 |
| AU2006226637A1 (en) | 2006-09-28 |
| EP1863817A1 (de) | 2007-12-12 |
| CA2602229A1 (en) | 2006-09-28 |
| US7569700B2 (en) | 2009-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125006T1 (el) | Λιπαρα οξεα και η χρηση τους σε συνδυασμο με βιομορια | |
| NO20090064L (no) | Pyrasoler som glucokinase aktivatorer | |
| WO2008108958A8 (en) | Benzimidazole derivatives and methods of use thereof | |
| ECSP099375A (es) | Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa | |
| WO2005009398A3 (en) | Tetracyclic benzamide derivatives and methods of use thereof | |
| WO2008150486A3 (en) | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors | |
| EA200900940A1 (ru) | Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное | |
| NO20084919L (no) | Oksadiazolidindionforbindelse | |
| EA200970088A1 (ru) | Модуляторы метаболизма и лечение связанных с ним нарушений | |
| WO2009023718A3 (en) | Novel activators of glucokinase | |
| NO20091596L (no) | Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer | |
| WO2008033460A3 (en) | Treating pain, diabetes, and lipid metabolism disorders | |
| NZ715983A (en) | Vasoprotective and cardioprotective antidiabetic therapy | |
| MX2010005186A (es) | Tiazolopiridinas solubilizadas. | |
| DE502006006107D1 (de) | Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| TW200635878A (en) | Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use | |
| TW200505880A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
| NO20054408L (no) | 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose | |
| NO20081681L (no) | N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| WO2008111956A3 (en) | Fatty acid oxidation inhibitors treating hyperglycemia and related disorders | |
| TW200616985A (en) | Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use | |
| WO2008035305A8 (en) | Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia | |
| ATE396997T1 (de) | Substituierte, bizyklische 8-pyrrolidino- benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| WO2008039087A3 (en) | Indoline derivatives and uses thereof | |
| WO2007029121A3 (en) | Novel cyclopent-2-en-1-one derivatives which are ppar receptor modulators, and use thereof in pharmaceutical or cosmetic compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |